Great pick up. In terms of MC across other imaging companies to name a few:
PME $2.7B SHL $15.4B HLS $2B IDX $786M M7T $206M
As 4DMedical is more about selling a SaaS product using existing equipment, I'm not sure how this would compare to other similar ASX listed companies that have a similar business model. What other ASX stocks people think 4DX compares to in terms of imaging and SaaS model? Key in working out MC is how much would each imaging cost per print for its clients and how many diagnostics will be performed per year.
With the initial IPO $45 million raising @ 73¢ a share and implying a $189 million MC or $138 million enterprise value. Big plus and tick is FDA already approved and potential TGA coming this year, there seems to be a lot of upside when compared to its MC of its peers.
"In 2019, the US spent more than US$13.7 billion on respiratory diagnostics through 73.5 million procedures.The Company’s second target market is Australia where US$281 million was spent to perform 5.3 million procedures in 2019."
(20min delay)